Good Manufacturing Practices Working Group. Working Group Members USA: Molzon Justina: Coordinator ARG: Rodolfo Mochetto BRA: Suzana Machado Marcelo.

Slides:



Advertisements
Similar presentations
Vatican City, 14 th November 2007 Gemma Rauret Director ESG and the current QA trends in Southern Europe: Spain Current trends in the European Quality.
Advertisements

World Health Organization
VII Conference of the Pan American Network on
PRESENTATION TO THE NATIONAL STAKEHOLDERS MEETING OF THE EAC REGIONAL STEERING COMMITTEE BY THE GMP TWG Presented by: Uganda, Kenya, United Republic of.
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
What’s New in the FDA’s Pharmaceutical Inspectorate and Risk Based Systems Inspection Rick Perlman Chair Food, Drug, and Cosmetic Division ASQ.
An Overview of Regulatory Harmonization Initiatives, Regulatory Networks and Collaboration In Latin America and the Caribbean Pan American Health Organization.
Update to IPC on MODEL QUALITY ASSURANCE SYSTEM FOR PROCUREMENT AGENCIES (MQAS) Dr Sabine Kopp 16 December 2014 Update to IPC on MODEL QUALITY ASSURANCE.
Presented at CLEAR’s 23rd Annual Conference Toronto, Ontario September, 2003 Public Accountability – Best Practices Accrediting Your Certification Program.
ICH-GCG June 2009 Pan American Health Organization CURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH): James Fitzgerald.
FDA’s Perspective Continued - Where We Are ?. GMP Task Groups.
Chapter 1 Introduction to Course and HACCP. Objective In this module, you will learn the: u Objective of the course u Format of the course u Expectations.
Justina A. Molzon, MS Pharm, JD
Regional Plan for Regulatory System For Blood, Blood Components and Blood Products Objective/Target: By 2012 all member states will have in place a functioning.
Wilbert Bannenberg SARPAM
Bioequivalence and Bioavailability Working Group.
THE MEETINGS OF MINISTERS OF JUSTICE OR OTHER MINISTERS OR ATTORNEYS GENERAL OF THE AMERICAS ("REMJA" PROCESS) Committee on Juridical and Political Affairs.
And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.
*The views expressed in this presentation are those of the presenter’s and do not necessarily represent the views of the U.S. Food and Drug Administration.
History and Importance of Terminology, the Terminology Landscape, and Options for Regulators Institute of Medicine Workshop International Regulatory Harmonization.
FDA’s Perspective on the “Pharmaceutical cGMPs for the 21st Century” Initiative David J. Horowitz, Esq. Director, CDER/FDA, Office of Compliance Advisory.
OAS/CICTE Maritime Security activities related to APEC Economies ( )
Development of Core Public Health Indicators for Decision Making. The PAHO’s Experience Carlos Castillo-Salgado, Special Advisor, Forum for Public Health.
Bioequivalence and Bioavailability Working Group.
(EQCP) EXTERNAL QUALITY CONTROL PROGRAM OF OFFICIAL CONTROL MEDICINE LABORATORIES Jose M. Parisi AMRO/PAHO December 5, 2007.
Working Group on Public Debt Progress Report 7th Meeting of the Steering Committee of the INTOSAI Committee on the Knowledge Sharing and Knowledge Services.
OAS/CICTE Maritime Security activities related to APEC Economies ( )
Slide 1 of 10D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.
Steering Committee Virtual Meeting February 27, 2012 Washington, DC NETWORK COMPONENT Ismael FOFANA AGRODEP Network Coordinator.
MISPA PROCESS May 19-20, 2010 Meeting of Caribbean Academics and Experts on Public Security: Looking ahead towards MISPA III.
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
FDA Public Meeting Preparation for the ICH Meetings in Tokyo, Japan, Including Progress on the Common Technical Document and Possibilities for New Topics.
ICH Quality Topics Update
WHO Regional Workshop on Good Manufacturing Practices for Blood Establishments Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
Round Table presentation on Implementation of PANDRH Guidelines in CARICOM countries.
Meeting to Strengthen the Capacity of Chemical Risk Assessment in LAC PAHO, December th, 2013 PAHO’s ANTECEDENTS ON TDS & INFORMATION ON LABORATORY.
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
Implementation of PANDRH Guidelines NAFTA Region VI PANDRH Conference Brasilia, July 2-8, 2011 Justina Molzon -- US Food and Drug Administration Mike Ward.
Round Table: Future challenges for PANDRH CARICOM Perspective.
VI Pan American Conference on Drug Regulatory Harmonization (CPANDRH) Conference Summary Brasilia, Brazil July Strengthening of National Regulatory.
EXTERNAL QUALITY CONTROL PROGRAM OF OFFICIAL DRUG QUALITY CONTROL LABORATORIES (EQCP) PROGRAMA DE CONTROL EXTERNO DE CALIDAD DE LABORATORIOS OFICIALES.
Round table Regulation of Medical Devices in the Americas: challenges and opportunities VII PANDRH Conference.
Presenter to insert their organization’s logo and information here PANDRH: Combat Counterfeit Medicines Working Group VII PANDRH Conference Ottawa, september.
Vision: Next Steps and Global Outreach Joan Wilmarth Blair Sr. Advisor, International Affairs Center for Biologics Evaluation and Research, FDA.
Biological Product Work Group GT BIO 6 th Pan-American Conference for the Harmonization of Pharmaceutical Regulations (CPARF) Brasilia, 06 – 08 July 2011.
WHO Technical Briefing Seminar
The IFPMA Code and how to set up a national self-regulation system Presentation to China/EU Pharmaceutical Industry Forum 17 May 2017, Shanghai, China.
The Codex Alimentarius Commission
PANDRH Strategic Development Plan :
Wilbert Bannenberg SARPAM
EAST AFRICAN COMMUNITY MEDICINES REGULATORY HARMONIZATION (EAC-MRH) PROJECT PROGRESS NAIROB I - KENYA By: EAC - Secretariat.
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Members of the GT/CFM MERCOSUR: Tiago Lanius Rauber, Brazil (Coordinator). ANDEAN COMMUNITY: Marisa Papen, Peru. SICA: Eric Conte, Panama. NAFTA: Michelle.
LEVEL OF ADOPTION AND IMPLEMENTATION OF THE TECHNICAL DOCUMENT N°7
Working Group Proposed Action Points 2017
Michelle Limoli, Pharm.D.
PANDRH Strategic Development Plan :
Reflections on International Cooperation
World Health Organization
Representation for the Americas
Washington, D.C., February 24, 2012
GMP Inspection Process
EXTERNAL QUALITY CONTROL PROGRAM OF OFFICIAL DRUG QUALITY CONTROL
Environmental Statistics
PAHO/WHO Collaborating Centre Regulation of Medical Devices
Regulation of Medical Devices in the Region of the Americas: main achievements and challenges Alexandre Lemgruber.
Representation for the Americas
cooperation in statistics Proposal for the organizational structure
GMP Legal Framework in Kyrgyzstan
Presentation transcript:

Good Manufacturing Practices Working Group

Working Group Members USA: Molzon Justina: Coordinator ARG: Rodolfo Mochetto BRA: Suzana Machado Marcelo Vogler de Moraes MEX: Sonia Zamudio Alonso CHI: Magdalena Reyes GUT: Norma de Pinto CAN: Louise Jodoin VEN: Elsa Castejón FIFARMA: Anthony Ventura ALIFAR: Marisela Benaim Resource Persons: Millie Barber/Arlene Badillo PAHO : Rosario D’Alessio >> Juanita Rodriguez

GMP Working Group Meetings March 3-4, 2002 — Caracas April 24-26, 2002 III Pan American Conference on Drug Regulatory Harmonization Washington, D.C May — Mexico City May 5-7, 2004 — Antigua, Guatemala Aug 30-Sept 1, 2004 — Dominican Republic March 2-4, 2005 IV Pan American Conference on Drug Regulatory Harmonization--Dominican Republic July 20-22, 2005 — Washington DC March 3-5, 2006 — Rockville, MD

Work Plan III Pan American Conference on Drug Regulatory Harmonization Washington, D.C April 24-26, 2002 Working Group meeting Training program design Implementation of training programs Mechanism for monitoring GMP implementation Identify GMP standards under development in other Forums (WHO and ICH) Consider mechanisms for joint inspections

IV Pan American Conference on Drug Regulatory Harmonization Dominican Republic 2-4 March 2005 Adopted the document: Guideline for Verification of Good Manufacturing Practices for the Pharmaceutical Industry WG to follow up on the adoption and evaluation of incorporating the Guideline for Verification of GMP in national regulations of the countries, and adoption of the Guideline by the subregional working groups WG to prepare a report on activities associated with training programs and advisory services and to present at the next Pan American Conference on Drug Regulatory Harmonization

Proposals to the Conference

Decision Tree for Implementing the Guideline for GMP Inspections The WG created a decision tree to promote the development of a national plan towards implementation of the Guideline for Verification of Good Manufacturing Practices for the Pharmaceutical Industry The decision tree would help national regulators and also the pharmaceutical industry since they will also be implementing the Guideline for Verification of GMP The proposed Decision Tree includes –Quality Assurance –Critical Supporting System –Validation and facilities

Adoption of ICH Q7 The WG GMP proposes the adoption of the ICH- Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients) as a Guideline for GMPs for APIs in the Americas The Secretariat reviewed the Spanish versions of Q-7 created by ANMAT and FDA A final draft was created and posted on the PANDRH web page for public comment The final version is presented to the Conference for adoption

Code of Ethics The WG GMP developed a model code of ethics It can be used by an Agency as a whole or only for inspectors of GMP It can be adopted or adapted by national agencies but the ideal is to have a Code of Ethics for the Region It covers requirements of good conduct, behavior, communications with the industry, loyalty to the agency, anti-discrimination policy, development and conflict of interest A final draft was posted on the PANDRH web page for public comment Presented to the Conference for adoption

Mutual Recognition of GMP Inspections PANDRH should promote harmonized procedures and information exchange among countries of the Americas A common guideline, educational opportunities and participation in joint inspections are essential for mutual recognition Ultimate goal is to build trust among NRA to promote efficient use of resources The WG proposes that the Conference explore mechanisms to promote mutual recognition